Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 6
2003 4
2004 8
2005 10
2006 8
2007 7
2008 9
2009 4
2010 2
2011 4
2012 3
2013 1
2014 2
2015 6
2016 4
2017 2
2018 1
2019 1
2020 4
2021 3
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

80 results

Results by year

Filters applied: . Clear all
Page 1
[18F]-fluoromisonidazole (FMISO) PET/MRI hypoxic fraction distinguishes neuroinflammatory pseudoprogression from recurrent glioblastoma in patients treated with pembrolizumab.
Barajas RF Jr, Ambady P, Link J, Krohn KA, Raslan A, Mallak N, Woltjer R, Muldoon L, Neuwelt EA. Barajas RF Jr, et al. Among authors: krohn ka. Neurooncol Pract. 2022 Mar 9;9(3):246-250. doi: 10.1093/nop/npac021. eCollection 2022 May. Neurooncol Pract. 2022. PMID: 35601969 Free PMC article.
18F-fluorodeoxyglucose (FDG) PET or 18F-fluorothymidine (FLT) PET to assess early response to aromatase inhibitors (AI) in women with ER+ operable breast cancer in a window-of-opportunity study.
Romine PE, Peterson LM, Kurland BF, Byrd DW, Novakova-Jiresova A, Muzi M, Specht JM, Doot RK, Link JM, Krohn KA, Kinahan PE, Mankoff DA, Linden HM. Romine PE, et al. Among authors: krohn ka. Breast Cancer Res. 2021 Aug 23;23(1):88. doi: 10.1186/s13058-021-01464-1. Breast Cancer Res. 2021. PMID: 34425871 Free PMC article.
18F-Fluoroestradiol PET Imaging in a Phase II Trial of Vorinostat to Restore Endocrine Sensitivity in ER+/HER2- Metastatic Breast Cancer.
Peterson LM, Kurland BF, Yan F, Jiresova AN, Gadi VK, Specht JM, Gralow JR, Schubert EK, Link JM, Krohn KA, Eary JF, Mankoff DA, Linden HM. Peterson LM, et al. Among authors: krohn ka. J Nucl Med. 2021 Feb;62(2):184-190. doi: 10.2967/jnumed.120.244459. Epub 2020 Jun 26. J Nucl Med. 2021. PMID: 32591490 Free PMC article. Clinical Trial.
Assessment of the Prognostic Value of Radiomic Features in 18F-FMISO PET Imaging of Hypoxia in Postsurgery Brain Cancer Patients: Secondary Analysis of Imaging Data from a Single-Center Study and the Multicenter ACRIN 6684 Trial.
Muzi M, Wolsztynski E, Fink JR, O'Sullivan JN, O'Sullivan F, Krohn KA, Mankoff DA. Muzi M, et al. Among authors: krohn ka. Tomography. 2020 Mar;6(1):14-22. doi: 10.18383/j.tom.2019.00023. Tomography. 2020. PMID: 32280746 Free PMC article.
Neurovascular Unit: Basic and Clinical Imaging with Emphasis on Advantages of Ferumoxytol.
Netto JP, Iliff J, Stanimirovic D, Krohn KA, Hamilton B, Varallyay C, Gahramanov S, Daldrup-Link H, d'Esterre C, Zlokovic B, Sair H, Lee Y, Taheri S, Jain R, Panigrahy A, Reich DS, Drewes LR, Castillo M, Neuwelt EA. Netto JP, et al. Among authors: krohn ka. Neurosurgery. 2018 Jun 1;82(6):770-780. doi: 10.1093/neuros/nyx357. Neurosurgery. 2018. PMID: 28973554 Free PMC article. Review.
Estrogen Receptor Binding (18F-FES PET) and Glycolytic Activity (18F-FDG PET) Predict Progression-Free Survival on Endocrine Therapy in Patients with ER+ Breast Cancer.
Kurland BF, Peterson LM, Lee JH, Schubert EK, Currin ER, Link JM, Krohn KA, Mankoff DA, Linden HM. Kurland BF, et al. Among authors: krohn ka. Clin Cancer Res. 2017 Jan 15;23(2):407-415. doi: 10.1158/1078-0432.CCR-16-0362. Epub 2016 Jun 24. Clin Cancer Res. 2017. PMID: 27342400 Free PMC article.
80 results